Clinical Trial Update: Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 dose-escalation/expansion study of CA-4948 as monotherapy in acute myeloid leukemia and myelodysplastic syndrome is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• CA-4948

Snippet

Sponsor: Curis, Inc. | Conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: SUSPENDED